Accès gratuit
Numéro
Med Sci (Paris)
Volume 23, Numéro 10, Octobre 2007
Page(s) 845 - 849
Section M/S revues
DOI https://doi.org/10.1051/medsci/20072310845
Publié en ligne 15 octobre 2007
  1. The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993; 72 : 971–83.
  2. Liévens JC, Birman S. La chorée de Huntington chez la drosophile et chez la souris: vers de nouvelles pistes thérapeutiques ? Med Sci (Paris) 2003; 19 : 593–9.
  3. Chneiweiss H. Les astrocytes contrôlent la neurogenèse dans le système nerveux central. Med Sci (Paris) 2002; 18 : 1065–6.
  4. Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 2005; 6 : 626–40.
  5. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65 : 1–105.
  6. Matute C, Domercq M, Sanchez-Gomez MV. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 2006; 53 : 212–24.
  7. Hansson E, Ronnback L. Glial neuronal signaling in the central nervous system. FASEB J 2003; 17 : 341–8.
  8. Singhrao SK, Thomas P, Wood JD, et al. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington’s, Alzheimer’s, and Pick’s diseases. Exp Neurol 1998; 150 : 213–22.
  9. Hebb MO, Denovan-Wright EM, Robertson HA. Expression of the Huntington’s disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats. FASEB J 1999; 13 : 1099–106.
  10. Shin JY, Fang ZH, Yu ZX, et al. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005; 171 : 1001–12.
  11. Cross AJ, Slater P, Reynolds GP. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington’s disease. Neurosci Lett 1986; 67 : 198–202.
  12. Arzberger T, Krampfl K, Leimgruber S, Weindl A. Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington’s disease-an in situ hybridization study. J Neuropathol Exp Neurol 1997; 56 : 440–54.
  13. Hermel E, Gafni J, Propp SS, et al. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington’s disease. Cell Death Differ 2004; 11 : 424–38.
  14. Vis JC, Schipper E, de Boer-van Huizen RT, et al. Expression pattern of apoptosis-related markers in Huntington’s disease. Acta Neuropathol (Berl) 2005; 109 : 321–8.
  15. Lievens JC, Woodman B, Mahal A, et al. Impaired glutamate uptake in the R6 Huntington’s disease transgenic mice. Neurobiol Dis 2001; 8 : 807–21.
  16. Behrens PF, Franz P, Woodman B, et al. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 2002; 125 : 1908–22.
  17. Nicniocaill B, Haraldsson B, Hansson O, et al. Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur J Neurosci 2001; 13 : 206–10.
  18. Rival T, Soustelle L, Strambi C, et al. Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain. Curr Biol 2004; 14 : 599–605.
  19. Liévens JC, Rival T, Iche M, Chneiweiss H, Birman S. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum Mol Genet 2005; 14 : 713–24.
  20. Kretzschmar D, Tschape J, Bettencourt Da Cruz A, et al. Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila. Glia 2005; 49 : 59–72.
  21. Custer SK, Garden GA, Gill N, et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 2006; 9 : 1302–11.
  22. Junier MP. What role(s) for TGFalpha in the central nervous system ? Prog Neurobiol 2000; 62 : 443–73.
  23. Figiel M, Maucher T, Rozyczka J, et al. Regulation of glial glutamate transporter expression by growth factors. Exp Neurol 2003; 183 : 124–35.
  24. Song C, Perides G, Liu YF. Expression of full-length polyglutamine-expanded Huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells. J Biol Chem 2002; 277 : 6703–7.
  25. Li SH, Yu ZX, Li CL, et al. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington’s disease. J Neurosci 2003; 23 : 6956–64.
  26. Bradley SV, Holland EC, Liu GY, et al. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Res 2007; 67 : 3609–15.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.